Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Next-Gen Immune Checkpoint Research

Brendan Curti

MD

🏢Providence Cancer Institute🌐USA

Director, Genitourinary Oncology Research

42
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Brendan Curti is a clinical immunotherapy researcher who has advanced novel immune checkpoint and co-stimulatory approaches in cancer. His work on OX40 agonists and novel checkpoint combinations has expanded the immunotherapy toolkit. He has contributed to early-phase clinical trials evaluating next-generation immune modulators in solid tumors.

Share:

🧪Research Fields 研究领域

OX40 agonists
Immune co-stimulation
Novel checkpoint targets
Melanoma clinical trials
Immunotherapy combinations

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Brendan Curti 的研究动态

Follow Brendan Curti's research updates

留下邮箱,当我们发布与 Brendan Curti(Providence Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment